Cotransplantation of human umbilical cord-derived mesenchymal stem cells and umbilical cord blood-derived CD34+ cells in a rabbit model of myocardial infarction

Molecular and Cellular Biochemistry

Volumn 387, Issue 1-2, 2014, Pages 91-100

  Li, Tong ^a   Ma, Qunxing ^a,b   Ning, Meng ^a   Zhao, Yue ^a   Hou, Yuelong ^a  

^a Tianjin Third Central Hospital   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Cotransplantation; Myocardial Infarction; Umbilical cord blood derived CD34+ Cells; Umbilical cord mesenchymal stem cells

Indexed keywords

ANIMALS; ANTIGENS, CD34; CELLS, CULTURED; CORD BLOOD STEM CELL TRANSPLANTATION; CORONARY VESSELS; FEMALE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; RABBITS; VENTRICULAR FUNCTION, LEFT;

EID: 84893861886     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1874-5     Document Type: Article

References (29)

1. Yang Jinfu, Zhou Wenwu, Zheng Wei, Ma Yanlin, Lin Ling, Tang Tao, Liu Jianxin, Jiefeng Yu, Zhou Xinmin, Jianguo Hu (2007) Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology 107:17-29. doi: 10.1159/000093609 (Pubitemid 46012429)
2. Mathieu Eva, Lamirault Guillaume, Toquet Claire, Lhommet Pierre, Rederstorff Emilie, Sourice Sophie, Biteau Kevin, Hulin Philippe, Forest Virginie, Weiss Pierre, Guicheux Jérôme, Lemarchand Patricia (2012) Intramyocardial delivery of mesenchymal stem cell-seeded hydrogel preserves cardiac function and attenuates ventricular remodeling after myocardial infarction. PLoS One 7(12):e51991. doi: 10.1371/journal.pone.0051991
3. Zhang J, Chen G-H, Wang Y-W, Zhao J, Duan H-F, Liao L-M, Zhang X-Z, Chen Y-D, Hu C (2012) Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction. Chin Med J 125(19):3472-3478. doi: 10.3760/cma.j.issn.0366-6999.2012.19.020
4. Latifpour M, Nematollahi-Mahani SN, Deilamy M, Azimzadeh BS, Eftekhar- Vaghefi SH, Nabipour F, Najafipour H, Nakhaee N, Yaghoubi M, Eftekhar-Vaghefi R, Salehinejad P, Azizi H (2011) Improvement in cardiac function following transplantation of human umbilical cord matrix-derived mesenchymal cells. Cardiology 120(1):9-18. doi: 10.1159/000332581
5. Wang J, Zhang S, Rabinovich B, Bidaut L, Soghomonyan S, Alauddin MM, Bankson JA, Shpall E, Willerson JT, Gelovani JG, Yeh ET (2010) Human CD34 cells in experimental myocardial infarction long-term survival, sustained functional improvement, and mechanism of action. Circ Res 106:1904-1911. doi: 10.1161/CIRCRESAHA.110.221762
6. Hu CH, Li ZM, Du ZM, Zhang AX, Rana JS, Liu DH, Yang DY, Wu GF (2010) Expanded human cord blood-derived endothelial progenitor cells salvage infarcted myocardium in rats with acute myocardial infarction. Clin Exp Pharmacol Physiol 37(5-6):551-556. doi: 10.1111/j.1440-1681.2010.05347.x
7. Pinho-Ribeiro V, Maia AC, Werneck-de-Castro JP, Oliveira PF, Goldenberg RC, Carvalho AC (2010) Human umbilical cord blood cells in infarcted rats. Braz J Med Biol Res 43(3):290-296
8. Lee WY, Tsai HW, Chiang JH, Hwang SM, Chen DY, Hsu LW, Hung YW, Chang Y, Sung HW (2011) Core-shell cell bodies composed of human cbMSCs and HUVECs for functional vasculogenesis. Biomaterials 32(33):8446-8455. doi: 10.1016/j.biomaterials.2011.07.061
9. Ma N, Stamm C, Kaminski A, Li W, Kleine HD, Müller-Hilke B, Zhang L, Ladilov Y, Egger D, Steinhoff G (2005) Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc Res 66(1):45-54. doi: 10.1016/j.cardiores.2004.12.013 (Pubitemid 40357867)
10. Schlechta B, Wiedemann D, Kittinger C, Jandrositz A, Bonaros NE, Huber JC, Preisegger KH, Kocher AA (2010) Ex-vivo expanded umbilical cord blood stem cells retain capacity for myocardial regeneration. Circ J 74(1):188-194. doi: 10.1253/circj.CJ-09-0409
11. Barclay GR, Tura O, Samuel K, Hadoke PW, Mills NL, Newby DE, Turner ML (2012) Systematic assessment in an animal model of the angiogenic potential of different human cell sources for therapeutic revascularization. Stem Cell Res Ther 3(4):23. doi: 10.1186/scrt114
12. Xinyang Hu, Shan Ping Yu, Fraser JL, Lu Z, Ogle ME, Wang JA, Wei L (2008) Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and Angiogenesis. J Thorac Cardiovasc Surg 135(4):799-808. doi: 10.1016/j.jtcvs. 2007.07.071 (Pubitemid 351417929)
13. Zhou C, Yang B, Tian Y, Jiao H, Zheng W, Wang J, Guan F (2011) Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes. Cell Immunol 272(1):33-38. doi: 10.1016/j.cellimm.2011.09.010
14. Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, VanderWerff I, Troyer D, McIntosh KR (2008) Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 26:2865-2874. doi: 10.1634/stemcells.2007-1028
15. Fujita M, Morimoto Y, Ishihara M, Shimizu M, Takase B, Maehara T, Kikuchi M (2004) A new rabbit model of myocardial infarction without endotracheal intubation. J Surg Res 116(1):124-128 (Pubitemid 38083294)
16. Rainsford E, Reen DJ (2002) Interleukin 10, produced in abundance by human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation. Br J Haematol 116(3):702-709 (Pubitemid 34178677)
17. English K, Barry FP, Field-Corbett CP, Mahon BP (2007) IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol Lett 110(2):91-100. doi: 10.1016/j.imlet.2007.04.001 (Pubitemid 46830943)
18. Schneider C, Jaquet K, Geidel S, Rau T, Malisius R, Boczor S, Zienkiewicz T, Kuck KH, Krause K (2009) Transplantation of bone marrow-derived stem cells improves myocardial diastolic function: strain rate imaging in a model of hibernating myocardium. J Am Soc Echocardiogr 22(10):1180-1189. doi: 10.1016/j.echo.2009.06.011
19. Malliaras K, Zhang Y, Seinfeld J, Galang G, Tseliou E, Cheng K, Sun B, Aminzadeh M, Marbán E (2013) Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse. EMBO Mol Med 5(2):191-209. doi: 10.1002/emmm.201201737
20. Takeda Y, Mori T, Imabayashi H, Kiyono T, Gojo S, Miyoshi S, Hida N, Ita M, Segawa K, Ogawa S, Sakamoto M, Nakamura S, Umezawa A (2004) Can the life span of human marrow stromal cells be prolonged by bmi-1, E6, E7, and/or telomerase without affecting cardiomyogenic differentiation? J Gene Med 6(8):833-845. doi: 10.1002/jgm.583 (Pubitemid 40228099)
21. Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, Suncion V, Morales AR, Da Silva J, Sussman MA, Heldman AW, Hare JM (2013) Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 127(2):213-223. doi: 10.1161/CIRCULATIONAHA.112.131110
22. Huang NF, Lam A, Fang Q, Sievers RE, Li S, Lee RJ (2009) Bone marrow-derived mesenchymal stem cells in fibrin augment angiogenesis in the chronically infarcted myocardium. Regen Med 4(4):527-538. doi: 10.2217/rme.09.32
23. Zhou Y, Wang S, Yu Z, Hoyt RF Jr, Qu X, Horvath KA (2011) Marrow stromal cells differentiate into vasculature after allogeneic transplantation into ischemic myocardium. Ann Thorac Surg 91(4):1206-1212. doi: 10.1016/j.athoracsur. 2011.01.021
24. Iso Y, Spees JL, Serrano C, Bakondi B, Pochampally R, Song YH, Sobel BE, Delafontaine P, Prockop DJ (2007) Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun 354(3):700-706. doi: 10.1016/j.bbrc.2007.01.045 (Pubitemid 46186241)
25. Sato T, Iso Y, Uyama T, Kawachi K, Wakabayashi K, Omori Y, Soda T, Shoji M, Koba S, Yokoyama S, Fukuda N, Saito S, Katagiri T, Kobayashi Y, Takeyama Y, Umezawa A, Suzuki H (2011) Coronary vein infusion of multipotent stromal cells from bone marrow preserves cardiac function in swine ischemic cardiomyopathy via enhanced neovascularization. Lab Invest 91(4):553-564. doi: 10.1038/labinvest.2010.202
26. Schneider RK, Neuss S, Knüchel R, Perez-Bouza A (2010) Mesenchymal stem cells for bone tissue engineering. Pathologe Suppl 2:138-146. doi: 10.1007/s00292-010-1329-7
27. Cheng H, Qiu L, Ma J, Zhang H, Cheng M, Li W, Zhao X, Liu K (2011) Replicative senescence of human bone marrow and umbilical cord derived mesenchymal stem cells and their differentiation to adipocytes and osteoblasts. Mol Biol Rep 38(8):5161-5168. doi: 10.1007/s11033-010-0665-2
28. Chen X, Zhang F, He X, Xu Y, Yang Z, Chen L, Zhou S, Yang Y, Zhou Z, Sheng W, Zeng Y (2013) Chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells in type I collagen-hydrogel for cartilage engineering. Injury 44(4):540-549. doi: 10.1016/j.injury.2012.09.024
29. Lu L-L, Liu Y-J, Yang S-G, Zhao Q-J, Wang X, Gong W, Han Z-B, Zhen-Shu X, Lu Y-X, Liu D, Chen Z-Z, Han Z-C (2006) Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91(8):1017-1026